NCT00927394View on ClinicalTrials.gov

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

1,143

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Hypertension
Interventions
DRUG

Aliskiren

Aliskiren 150 mg tablet

DRUG

Valsartan

Valsartan 160 mg capsules

DRUG

Placebo for Aliskiren

Placebo for Aliskiren 150 mg tablets

DRUG

Placebo for Valsartan

Placebo for Valsartan 160 mg capsules

Trial Locations (4)

USA

Investigative Site, Newark

Unknown

Investigative Site, Kansas City

Investigative Site, Camden

Investigative Site, Philadelphia

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00927394 - Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus | Biotech Hunter | Biotech Hunter